PEAK6 Group’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$3.14M Sell
331,317
-82,653
-20% -$792K 0.01% 1032
2018
Q1
$4.22M Buy
413,970
+28,291
+7% +$289K 0.02% 901
2017
Q4
$3.84M Buy
385,679
+210,022
+120% +$2.3M 0.02% 965
2017
Q3
$1.95M Buy
175,657
+13,657
+8% +$160K 0.01% 1401
2017
Q2
$1.54M Sell
162,000
-54,054
-25% -$431K 0.01% 1563
2017
Q1
$1.44M Sell
216,054
-8,946
-4% -$53K 0.01% 1381
2016
Q4
$1.38M Sell
225,000
-18,867
-8% -$94K 0.01% 1593
2016
Q3
$1.25M Sell
243,867
-6,750
-3% -$36K 0.01% 1604
2016
Q2
$1.44M Sell
250,617
-15,683
-6% -$95.4K 0.01% 1499
2016
Q1
$1.62M Hold
266,300
0.01% 1306
2015
Q4
$1.7M Hold
266,300
0.01% 1482
2015
Q3
$1.6M Buy
266,300
+141,300
+113% +$878K 0.01% 1757
2015
Q2
$770K Buy
+125,000
New +$767K ﹤0.01% 2341

Other funds holding CO

PEAK6 Group's CO Position: Q2 2018 in Review

PEAK6 Group reduced its Global Cord Blood Corporation (CO) stake by 20% in Q2 2018, selling an estimated $792K and leaving 331,317 shares worth $3.14M. The position accounts for 0.01% of the portfolio, ranked #1032.

PEAK6 Group first reported a position in CO in Q2 2015 and has held it in 13 quarters since. The position peaked at $4.22M in Q1 2018. 46 funds tracked by Wall St. Rank hold CO as of Q2 2018.

  • PEAK6 Group held 331,317 shares of Global Cord Blood Corporation worth $3.14M as of Q2 2018.
  • PEAK6 Group sold 82,653 Global Cord Blood Corporation shares in Q2 2018, an estimated $792K.
  • Global Cord Blood Corporation made up 0.01% of PEAK6 Group's portfolio in Q2 2018, its #1032 holding.
  • PEAK6 Group first reported a position in Global Cord Blood Corporation in Q2 2015 and has held it in 13 quarters since.
  • PEAK6 Group's Global Cord Blood Corporation position peaked at $4.22M in Q1 2018.
  • 46 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.